Semaglutide
GLP-1 receptor agonist used in medical weight loss and metabolic protocols.
GLP-1 receptor agonists are the most-requested peptide class in U.S. medical wellness in 2026. Reliable supply, batch-to-batch consistency, and clear 503B/503A documentation are non-negotiable for clinics and pharmacies operating in this category.

3 products listed below. Each links to the full product detail page with formats, purity, and a Certificate of Analysis sample.
GLP-1 receptor agonist used in medical weight loss and metabolic protocols.
Dual GIP/GLP-1 receptor agonist used in medical weight loss and metabolic care.
Triple-agonist (GLP-1/GIP/glucagon) peptide currently for 503A compounding only.
Every shipment includes a per-lot Certificate of Analysis with identity confirmation, HPLC purity, endotoxin testing, and sterility (where applicable).
Format availability varies by SKU. Each product page lists which formats are available — 503B finished dose for clinics, 503A bulk API for pharmacies, or both.
Temperature-sensitive SKUs ship in validated insulated coolers with tracking. Storage guidance is included with each shipment.